When UC Berkeley biochemist Jennifer Doudna first began studying how bacteria fight virus infections, she had no idea it ...
KOL panel to discuss how vispa-cel, an anti-CD19 allogeneic CAR-T cell therapy, can broaden access for patients with second-line large B cell lymphoma including through use in the community setting ...
According to The New England Journal of Medicine, investigators at Uppsala University Hospital implanted a product called ...
So, even via the more modest predictions, people will be able to double their longevity. When you reach 100 years old, you ...
If approved, Regeneron and Tessera's TSRA-196 could become the first curative therapy to reach patients with AATD, who have ...
HIV treatment has entered a revolutionary new era, one where a single yearly injection can keep the virus undetectable, and ...
Metagenomi, Inc. (Nasdaq: MGX) (the 'Company”), an in vivo genome editing company capitalizing on its proprietary ...
A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.
CRISPR Therapeutics AG (NASDAQ:CRSP) is among the top 10 stocks to buy from Cathie Wood’s stock portfolio. CRISPR made up ...
This year has seen the approval of several first-in-class therapies for HAE, but in a fragmented space, experts question ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback